Book closure period for extraordinary general meeting
Filed with HKEX · Stock code 1952 · · 1 page · English
Summary by 6ix AI
This filing is a notice regarding the book closure period for an extraordinary general meeting of Everest Medicines Ltd. The meeting is scheduled for a specific date, and the record date for shareholder eligibility is also provided. The notice outlines the period during which the register of members will be closed for share transfers. It specifies the deadline for unregistered shareholders to submit transfer documents for registration.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Everest Medicines
- Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Terms of reference of the environmental, social and governance committee
- List of directors and their roles and functions
- Establishment of environmental, social and governance committee
Later from Everest Medicines
- (1) Continuing connected transactions in relation to the strategic cooperation framework agreement; and (2) notice of extraordinary general meeting
- Notice of extraordinary general meeting
- Form of proxy for the extraordinary general meeting to be held on Monday, 16 November 2026
- The Strategic Cooperation Framework Agreement
- Notification Letter to Registered Shareholders - Virtual Meeting Arrangements for the Extraordinary General Meeting
Follow Everest Medicines into a list and get an email when it puts out news.
Follow Everest Medicines